Tech Company Financing Transactions
Gyala Therapeutics Funding Round
On 2/11/2026, Gyala Therapeutics secured $4.4 million in funding from Ministry of Science and Innovation of Spain.
Transaction Overview
Company Name
Announced On
2/11/2026
Transaction Type
Venture Equity
Amount
$4,400,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate its Phase I/IIa clinical trial of GYA01 following authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Barcelona, Undisclosed
Spain
Barcelona, Undisclosed
Spain
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Gyala Therapeutics develops cell therapies for the treatment of hematological malignancies with clinical unmet need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Claudio Santos
Browse more venture capital transactions:
Prev: 2/11/2026: Tenna Systems venture capital transaction
Next: 2/11/2026: Deep Space Energy venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs